Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Sch-417690

Known as: SCH-D, Sch 417690, Sch417690 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Vicriviroc Maleatevicriviroc

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).
Vicriviroc or SCH 417690 is a potent and selective antagonist of the CCR5 receptor. CCR5 receptor antagonists have the potential… 
2011
2011
Epitaxial Structure Design of a Long-Wavelength InAlGaAs/InP Transistor Laser
The threshold condition in long-wavelength InAlGaAs/InP transistor lasers is theoretically and numerically investigated. The… 
  • figure 1
  • figure 2
  • figure 5
  • figure 3
  • figure 4
2008
2008
Molecular Interactions of CCR 5 with Major Classes of Small-Molecule Anti-HIV CCR 5 Antagonists
In addition to being an important receptor in leukocyte activation and mobilization, CCR5 is the essential coreceptor for human… 
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2007
Highly Cited
2007
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry.
Human immunodeficiency virus type 1 (HIV-1) infection can be inhibited by small molecules that target the CCR5 coreceptor. Here… 
Review
2006
Review
2006
Serious Doubts on Safety and Efficacy of CCR5 Antagonists
Entry inhibitors constitute a new drug class for treatment of HIV-1 infection. They are divided into subclasses, each aiming at a… 
Highly Cited
2005
Highly Cited
2005
Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
We describe the generation of two genetically related human immunodeficiency virus type 1 (HIV-1) isolates highly (>20,000-fold… 
2005
2005
The method of treating hiv infections comprising both administering tipranavir and sch-417690
Method of treating HIV infection due to the fact that both the administration of tipranavir and SCH-417690. 
Highly Cited
2005
Highly Cited
2005
Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1
ABSTRACT Inhibiting human immunodeficiency virus type 1 (HIV-1) infection by blocking the host cell coreceptors CCR5 and CXCR4 is… 
Highly Cited
1989
Highly Cited
1989
Synthesis of Research on School-Based Management
D adc County, Florida, has made front-page headlines with its pilot School-Based Manage ment/Shared Decision Making Pro gram The… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE